Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.
Dosage and administration
Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses. NOTE: Proparacaine hydrochloride ophthalmic solution should be clear to straw-color. If the solution becomes darker, discard the solution.
Proparacaine hydrochloride ophthalmic solution 0.5% is a topical
local anesthetic for ophthalmic use. The active ingredient is represented by the
structural formula:
PROPARACAINE OPHTH SOL Struct Image
Molecular Weight: 330.85
Established name: Proparacaine Hydrochloride
Chemical name: Benzoic acid, 3-amino-4-propoxy-,2-(diethylamino) ethyl ester,
monohydrochloride.
Each mL contains: Active: proparacaine hydrochloride
5mg 0.5%. Preservative: benzalkonium chloride (0.01%).
Inactives: glycerin; and purified water. The pH may be
adjusted with hydrochloric acid and/or sodium hydroxide.
CLINICAL PHARMACOLOGY
CLINICAL PHARMACOLOGY SECTION
Proparacaine hydrochloride ophthalmic solution is a
rapidly-acting topical anesthetic, with induced anesthesia lasting approximately
10-20 minutes.
INDICATIONS AND USAGE
INDICATIONS & USAGE SECTION
Proparacaine hydrochloride ophthalmic solution is indicated for
procedures in which a topical ophthalmic anesthetic is indicated: corneal
anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal
foreign bodies, and for short corneal and conjunctival procedures.
CONTRAINDICATIONS
CONTRAINDICATIONS SECTION
Proparacaine hydrochloride ophthalmic solution should be
considered contraindicated in patients with known hypersensitivity to any of the
ingredients of this preparation.
WARNINGS
WARNINGS SECTION
NOT FOR INJECTION - FOR TOPICAL OPHTHALMIC USE ONLY. Prolonged
use of a topical ocular anesthetic is not recommended. It may produce permanent
corneal opacification with accompanying visual loss.
PRECAUTIONS
PRECAUTIONS SECTION
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term studies in animals have not been performed to evaluate
carcinogenic potential, mutagenicity, or possible impairment of fertility in
males or females.
Pregnancy
Pregnancy Category C: Animal reproduction studies have not been
conducted with proparacaine hydrochloride ophthalmic solution 0.5%. It is also
not known whether proparacaine hydrochloride can cause fetal harm when
administered to a pregnant woman or can affect reproduction capacity.
Proparacaine hydrochloride should be administered to a pregnant woman only if
clearly needed.
Nursing Mothers
It is not known whether this drug is excreted in human milk.
Because many drugs are excreted in human milk, caution should be exercised when
proparacaine hydrochloride is administered to a nursing woman.
Pediatric Use
Safety and effectiveness of proparacaine hydrochloride ophthalmic
solution in pediatric patients have been established. Use of proparacaine
hydrochloride is supported by evidence from adequate and well-controlled studies
in adults and children over the age of twelve, and safety information in
neonates and other pediatric patients.
Geriatric Use
No overall clinical differences in safety or effectiveness have
been observed between the elderly and other adult patients.
ADVERSE REACTIONS
ADVERSE REACTIONS SECTION
Occasional temporary stinging, burning and conjunctival redness
may occur with the use of proparacaine. A rare, severe, immediate-type,
apparently hyperallergic corneal reaction characterized by acute, intense and
diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of
large areas of necrotic epithelium, corneal filaments and, sometimes, iritis
with descemetitis has been reported.
Allergic contact dermatitis from proparacaine with drying and fissuring of
the fingertips has also been reported.
DOSAGE AND ADMINISTRATION
DOSAGE & ADMINISTRATION SECTION
Usual Dosage: Removal of foreign bodies
and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each
eye before operating.
Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10
minutes for 5 to 7 doses.
NOTE: Proparacaine hydrochloride ophthalmic solution
should be clear to straw-color. If the solution becomes darker, discard the
solution.
HOW SUPPLIED
HOW SUPPLIED SECTION
Proparacaine hydrochloride ophthalmic solution 0.5% is supplied
in 15 mL DROP-TAINER® dispensers.
NDC # 16590-195-15
Storage: Bottle must be stored in unit carton to
protect contents from light. Store bottles under refrigeration at 2° - 8°C (36°
- 46°F).
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.